BioCentury
ARTICLE | Company News

Lifecore deal

January 9, 1995 8:00 AM UTC

The initial development phase of the agreement is expected to generate revenues of $330,000 for LCBM, which is looking to offset costs of unused hyaluronate production capacity by marketing the specia...